A NEW wound care product is set
to debut in Australia, distributed by
a company headed up by former
Novogen gm Craig Kearney.
US wound management specialist
Uluru Inc yesterday announced the
first Australian shipment of its
Altrazeal, which is described as
“incorporating the features and
benefits of the desired ‘ideal’
wound dressing”.
An extensive pre-marketing
program has already been locally
conducted, and initial customers
already include a “significant state
government contract”.
Altrazeal will be launched in a two
gram pouch for the private market,
followed by a 0.75 gram blister ...
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 02 Aug 12
Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.
To sign up for a free subscription, click on the button at right.
